|
| |
PharmionPharmion is a global specialty pharmaceutical company that is dedicated to the hematology and oncology communities. With proven development and regulatory professionals and an experienced global commercialization team, we concentrate our resources on acquiring, developing, and commercializing innovative products.
We work in partnership with a network of scientific and clinical advisors to identify and develop these products for global markets. To expand each product's potential, we have established our own commercial organizations in the United States, Europe, and Australia and have created distribution partnerships in 30 additional countries. With this international network we can reach physicians and their patients in more than 40 countries.
Through these efforts, we seek to provide greater therapeutic options to hematologists and oncologists with the ultimate goal of extending survival and improving patients' quality of life.
| Contact Details: |
| 2525 28th St., Suite 200 |
| Boulder |
| CO |
| 80301 |
| United States of America |
| Tel: | +1 720 564 9100 |
| Fax: | +1 720 564 9191 |
| Email: | IR@Pharmion.com |
| WWW: | www.pharmion.com/
|
|
Loading...
|
Press Releases on Pharmion:
|
 |
| Reportlinker Adds Anticoagulants - A Global Market Review |
18th November, 2009 |
Reportlinker |
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.
Anticoagulants - A Global Market Review
http://www.reportlinker.com
|
| New Report Just Published: World Multiple Myeloma Therapeutics Market Report |
7th July, 2009 |
Reportlinker |
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue.
World Multiple Myeloma Therapeutics Market
http://www.reportlinker.com/p0119496/World
|
| Clovis Oncology Raises $145 Million in Start-Up Financing |
21st May, 2009 |
Clovis Oncology, Inc. |
- New company founded by members of former Pharmion executive team
- Company focused on acquiring, developing and marketing innovative anti-cancer compounds
BOULDER, Colo., May 21 /PRNewswire/ --
|
| Alan Hartman, Richard Girling and Mark Robinson to Join Centerview Partners to Build Healthcare Sector Advisory Practice |
15th April, 2009 |
Centerview Partners |
NEW YORK, April 15 /PRNewswire/ -- Centerview Partners announced that Alan
Hartman, Richard Girling and Mark Robinson, three leading investment bankers
specializing in the healthcare sector, have
|
| Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors |
2nd March, 2009 |
Orexigen Therapeutics, Inc. |
SAN DIEGO, March 2 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) today announced that Patrick Mahaffy has been appointed to the Company's Board of Directors to fill an
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 466 times since April 2007, the link to the organisation's website has been followed 55 times Recent Search Terms used to find this page: pharmion | Pharmion USA | clovis therapeutics | clovis pharmion | pharmion contact details | pharmion Clovis oncology | Pharmion Inc | pharmion san francisco | Clovis Oncology five cancer therapies | Clovis Oncology five cancer therapies | . Search for more companies in Boulder Search for more companies in CO This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for Pharmion |
